title: [Indications, techniques and outcomes of high-intensity focused ultrasound (HIFU) for the treatment of localized prostate cancer].
abstract: High-intensity focused ultrasound (HIFU) is a minimally invasive alternative for patients with localized prostate cancer, not suitable for radical prostatectomy because of a life expectancy less than 10 years or because of major co-morbidities precluding surgery. HIFU can be performed in patients with LUTS (associated TURP) or with a previous history of BPH surgery. HIFU is repeatable after the initial procedure if a recurrent cancer is diagnosed on control biopsies. Furthermore, this therapy is a viable option for patients with a local relapse after external beam radiation therapy: oncologic efficacy is conversely related to the initial prostate cancer stage before radiation therapy.
authors.affiliation: Hôpital edouard Herriot, 5, place d'Arsonval, 69437 Lyon 03, France.
authors.forename: L
authors.initials: L
authors.lastname: Poissonnier
authors.forename: F J
authors.initials: FJ
authors.lastname: Murata
authors.forename: J Y
authors.initials: JY
authors.lastname: Chapelon
authors.forename: A
authors.initials: A
authors.lastname: Gelet
mesh_terms: D003663:Decision Trees; D004867:Equipment Design; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000628:therapy*; D016896:Treatment Outcome; D036761:Ultrasound, High-Intensity Focused, Transrectal / Q000295:instrumentation / Q000379:methods